Catalyst Wire Dossier Catalyst Wire Dossier

TRILEPTAL

OXCARBAZEPINE · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for TRILEPTAL, covering 2007-01-09 to 2025-09-23. Get the full timeline:

Most recent: FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing